{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:21:35Z","timestamp":1762309295752,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nrleng.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:15:13Z","timestamp":1762308913000},"page":"875-883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis"],"prefix":"10.1016","volume":"40","author":[{"given":"A.","family":"Rivero-de-Aguilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mascare\u00f1as-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"P\u00e9rez-R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Llaneza-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mulero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mendibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0.","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Meca-Lallana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Landete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Vizoso Hermida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Carrascal Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruano-Ravi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Puente-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Varela-Lema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2025.08.003_bib0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0125","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler J"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/joim.13215","article-title":"Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis","volume":"289","author":"Piehl","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0135","series-title":"Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis \u2013 Revision 2","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2015"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0140","series-title":"Critical appraisal of scientific articles","author":"du Prel","year":"2009"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0145","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0150","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0022-510X(11)70007-7","article-title":"Review of methodological issues of clinical trials in multiple sclerosis","volume":"311","author":"Montalban","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13167-019-00192-z","article-title":"Suggestions for improving the design of clinical trials in multiple sclerosis \u2013 results of a systematic analysis of completed phase III trials","volume":"10","author":"Gehr","year":"2019","journal-title":"EPMA J"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0160","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0165","unstructured":"Critical Assessment Skills Programme. CASP Randomised Controlled Trial Standard Checklist [Internet]. Available from: https:\/\/casp-uk.net\/casp-tools-checklists\/randomised-controlled-trial-rct-checklist\/ [cited 26.02.23]."},{"key":"10.1016\/j.nrleng.2025.08.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40263-017-0412-5","article-title":"Outcome measures in clinical trials for multiple sclerosis","volume":"31","author":"van Munster","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0180","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419826547","article-title":"Evolution of clinical trials in multiple sclerosis","volume":"12","author":"Zhang","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000821","article-title":"Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes","volume":"33","author":"Brichetto","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0190","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/biom11091342","article-title":"Measuring treatment response in progressive multiple sclerosis \u2013 considerations for adapting to an era of multiple treatment options","volume":"11","author":"Krajnc","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0195","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","article-title":"The 2013 clinical course descriptors for multiple sclerosis","volume":"94","author":"Lublin","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0200","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1212\/WNL.0000000000002471","article-title":"The challenge of comorbidity in clinical trials for multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(14)70264-9","article-title":"Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives","volume":"14","author":"Ontaneda","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/WCO.0000000000000697","article-title":"Multiple sclerosis: clinical trial design 2019","volume":"32","author":"Pardini","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrneurol.2017.171","article-title":"Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting","volume":"14","author":"Tur","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0220","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40263-018-0530-8","article-title":"Disability outcome measures in phase III clinical trials in multiple sclerosis","volume":"32","author":"Uitdehaag","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.zefq.2022.04.025","article-title":"Reporting guidelines for Delphi techniques in health sciences: a methodological review","volume":"172","author":"Spranger","year":"2022","journal-title":"Z Evid Fortbild Qual Gesundhwes"},{"key":"10.1016\/j.nrleng.2025.08.003_bib0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2288-5-37","article-title":"Stability of response characteristics of a Delphi panel: application of bootstrap data expansion","volume":"5","author":"Akins","year":"2005","journal-title":"BMC Med Res Methodol"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082500080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082500080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:55Z","timestamp":1762309015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217358082500080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S217358082500080X"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.003","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}